Anzeige
Mehr »
Login
Freitag, 18.10.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
5 Millionen Unzen und steigend: NexGold Mining's unerschlossene Goldstraße
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0MVLL | ISIN: HK0656038673 | Ticker-Symbol: FNI
Tradegate
17.10.24
08:26 Uhr
0,550 Euro
+0,012
+2,14 %
1-Jahres-Chart
FOSUN INTERNATIONAL LTD Chart 1 Jahr
5-Tage-Chart
FOSUN INTERNATIONAL LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,5410,54907:24
0,5290,54917.10.
PR Newswire
195 Leser
Artikel bewerten:
(1)

Fosun's Global Operations Focus on the Middle East to Explore New Growth Prospects

HONG KONG, Oct. 9, 2024 /PRNewswire/ -- Among many Chinese private enterprises, Fosun stands out for its early start in globalization, firm execution, and strong operational capabilities.

Recently, Fosun has been very active in the Middle East region. In September, Fosun's subsidiary, Hainan Mining's wholly owned subsidiary, Roc Oil, made a full offer to acquire Tethys Oil AB for approximately RMB 1.302 billion, aiming to acquire oil field rights in several blocks in Oman.

In July, Hainan Mining signed a memorandum of understanding with Ajlan & Bros Holding to explore the feasibility of a lithium salt plant project in Saudi Arabia. They also plan to establish an industrial fund focused on upstream lithium resources, local mineral exploration, and global investments in new energy metal resources and technology.

In the same month, FFT, a global leader in flexible automation production line solutions under Fosun, signed a joint venture agreement with Saudi family business Khaled Juffali Company (KJC). The plan is to establish a commercial technology entity in Saudi Arabia, and collaborate with Shanghai Easun Technology, FFT's parent company under Fosun, to provide automated production line solutions for Saudi Arabia's electric vehicle industry. The joint venture has already secured its first project in Saudi Arabia's automotive sector.

Moreover, FFT plans to expand into other industries in Saudi Arabia that require automation and robotic assembly. With its extensive expertise in automation and robotics technology, FFT is expected to set new industry standards in Saudi Arabia.

In May, Club Med, a global leader in all-inclusive holidays, announced its entry into the Middle East market, launching its first project in Oman-Club Med Musandam. This project marks a deep collaboration between Club Med, the Royal Court Affairs of Oman, and Omran Group. The resort is set to begin construction in early 2026 and is expected to open in 2028.

"The Best Strategic Partner"

With its vibrant and robust economic growth, the Middle East is becoming a key frontier for Fosun's global operations. Achieving multiple industrial and project results in such a short time demonstrates Fosun's efficient execution and underscores its confidence and determination in the Middle Eastern market.

Fosun International Chairman, Guo Guangchang, stated: "Fosun looks forward to establishing long-term and stable strategic cooperation with more Middle Eastern partners. As a company with global operational capabilities and deep roots in the Chinese market, I believe Fosun is the best strategic partner. With our global operational capabilities and extensive experience, Fosun can achieve sustainable value growth with Middle Eastern partners and create a new win-win ecosystem."

Under the guidance of Saudi Arabia's "Vision 2030", the country is quickly becoming a hub for sports, especially esports. At the recent Esports World Cup held in Riyadh, Fosun Sports' Wolves Esports Club won two championships in "Teamfight Tactics" and "Honor of Kings." With Saudi Arabia's continued investment in esports and Fosun Sports' excellent performance in both football and esports, further collaboration between the two sides is expected.

As one of the pioneers of Fosun's global expansion, Fosun Pharma is accelerating its layout in the Middle East market. In June, Fosun Pharma's Henlius' biosimilar drug HANQUYOU was launched in Saudi Arabia, likely becoming the first domestic monoclonal antibody drug to enter the Middle Eastern market.

Global Operations Rooted in China

Fosun's globalization began in 2007 when Fosun International was listed in Hong Kong, marking over 17 years of global operations. Its diverse industries cover pharmaceuticals, tourism, insurance, sports, energy, fashion, medical technology, intelligent manufacturing, and more. Through its "global operations + local organization" model, Fosun has facilitated mutual empowerment across different industries and countries, achieving rapid growth.

In the first half of 2024, Fosun's total revenue reached RMB 97.84 billion, of which overseas revenue was RMB 45.87 billion, a year-on-year increase of 4%, accounting for 47% of the total revenue. Over the past ten years, Fosun's overseas revenue has had a compound annual growth rate of 55%. Fosun now has an extensive business presence in more than 35 countries and regions globally.

Since Club Med joined Fosun in 2015, it has continuously expanded its global market, now operating nearly 70 premium resorts across six continents. It has also launched new product lines for the Chinese market, achieving rapid growth. In the first half of 2024, Club Med's revenue reached RMB 8.89 billion, a year-on-year increase of 10.3%, further consolidating its global leadership in mountain resorts.

In 2014, Fosun acquired Fidelidade, the largest insurance company in Portugal. Over the past decade, through deep industrial operations and resource synergy, Fosun has successfully expanded Fidelidade's business to 12 countries across Europe, Africa, and Latin America. In 2023, Fidelidade's total international business premiums reached EUR 1.7 billion, a year-on-year increase of 11%. The share of international business has grown from 6% in 2017 to 17% in 2023.

Guo Guangchang, Chairman of Fosun International, said: "We are proud to have become one of the few Chinese companies rooted in China with global operational capabilities. Fosun will continue to advance its globalization strategy, transforming its global capabilities into sustained profit growth."

In its global operations, Fosun excels at collaborating with local governments, accumulating rich experience and resources, and successfully aligning projects with national policies. With Fosun's increased investment in the Middle East, its global network and operational capabilities provide strong support for the successful implementation of projects, ensuring alignment with national development goals and successful project execution.

With its global operational capabilities, Fosun not only deeply understands the Chinese market but also brings new opportunities to Middle Eastern enterprises and investors through its replicable global experience.

Cision View original content:https://www.prnewswire.co.uk/news-releases/fosuns-global-operations-focus-on-the-middle-east-to-explore-new-growth-prospects-302271268.html

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.